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Abstract
Objective To determine whether hospital stay 
predisposes to nasal colonisation with Staphylococcus 
aureus and Methicillin Resistant S. aureus (MRSA).
Method Nasal swabs were taken from cadavers 
undergoing post-mortem examinations at the mortuary 
of St. Luke’s Hospital.  The swabs were taken to the 
Bacteriology Laboratory where attempts were made to 
culture S. aureus.  Vitek® Gram Positive Susceptibility Cards 
were used for antibiotic susceptibility.  MRSA positive 
organisms were tested using Penicillin Binding Protein 
Latex Agglutination.  
Key Findings Ninety-three swabs were taken.  The 
proportion of S. aureus nasal carriage was similar in both 
hospitalised and non-hospitalised groups.  However, 8 out 
of 15 (53%) S. aureus carriers in the hospitalised group were 
MRSA positive, compared to 4 out of 19 (21%) S. aureus 
carriers in the non-hospitalised group.
Conclusion Hospitalisation increases the 
incidence of MRSA carriage compared to the non-
hospitalised population.  
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METHICILLIN RESISTANT S. AUREUS 
IN AUTOPSY CASES
Introduction
Staphylococcus aureus is an important cause of human 
disease.  Although it is most often associated with skin 
and soft tissue infections, it has numerous manifestations 
including conditions with low morbidity and mortality, 
such as folliculitis and food poisoning, and others which 
cause fatal systemic illnesses, such as endocarditis and 
toxic shock syndrome.1 
S. aureus colonises between 30 to 50 percent of the 
healthy adult population.2 The anterior nares are the most 
consistent site of colonisation.1 Although the bacteria are 
normally harmless, they can cause serious infections when 
the opportunity arises.3 S. aureus can develop resistance to 
a wide variety of antibiotics.  Methicillin resistance confers 
resistance to all penicillinase-resistant penicillins and 
cephalosoporins.2 MRSA infections have been associated 
with increased morbidity and mortality and hospital costs.4
Nasal carriage of S. aureus has become a means of 
persistence and spread of multiresistant Staphylococci, 
especially MRSA. Because MRSA can resist practically all 
types of antibiotics, they have become a public health 
threat, in the context of hospital-acquired infections and 
more recently as community-acquired diseases.5 Factors 
associated with MRSA colonisation include prior antibiotic 
exposure, particularly incomplete or repeated courses of 
antibiotics, prolonged hospitalisation, surgery, admission 
to an intensive care unit, living in a nursing home, and 
close proximity to a patient colonised or infected with 
MRSA.6
The aim of the study was to determine whether hospital 
stay predisposes to nasal colonisation with S. aureus 
and MRSA by comparing two cohorts, one which was 
hospitalised and one that had not been admitted to 
hospital within the previous six months.
 
Method
Nasal swabs were taken from cadavers undergoing 
post-mortem examinations.  These were divided into 
2 categories, those that were hospitalised for at least 
24 hours and those that were not hospitalised in the 
previous 6 months.  Individuals who had drowned or who 
had severe facial injuries were excluded from the study. 
Approval from the Faculty and University Research Ethics 
Committee was obtained to carry out this project.  
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The nasal swabs were taken to the Bacteriology Laboratory 
at St. Luke’s Hospital (SLH) where attempts were made to 
culture S. aureus.  In this way S. aureus nasal carriers were 
identified.  The nasal swab was first cultured on Mannitol 
Salt Agar (MSA), which is a selective medium for the 
isolation of Staphylococcus. spp. Most other bacteria are 
inhibited by the high salt concentration.  Yellow colonies 
from the MSA were sub-cultured on blood agar, nutrient 
agar and DNAse agar. Catalase, coagulase and DNAse tests 
were then performed.  S. aureus is catalase, coagulase and 
DNAse positive.  A Gram-stain was also done to verify that 
the organisms were Gram positive cocci in clusters.
S. aureus organisms were further tested for their antibiotic 
susceptibility using Vitek® Gram Positive Susceptibility 
Cards which indicates the range of antibiotics that the 
organism is sensitive or resistant to.  MRSA positive 
organisms were tested using Penicillin Binding Protein 
(PBP) Latex Agglutination, which is a confirmatory test for 
MRSA, since it detects the mutant enzyme PBP2a.
Results
A total of 93 swabs were taken from cadavers undergoing 
post-mortem examination during the period of study (12 
months). The number of cases studied is heavily weighted 
in favour of the male sex.  There were approximately equal 
numbers of cadavers in each age group with a mean age 
of 55 years (range 13 to 93 years).  Out of the 65 males, 
24 were hospitalised and 41 were not hospitalised.  From 
the 28 females, 18 were hospitalised and 10 were not 
hospitalised.  
Figure 1 shows the incidence of S. aureus in the nasal 
swabs studied in both hospitalised and non-hospitalised 
cases.  The proportion of S. aureus nasal carriage was 
similar in both groups, with 36% of the hospitalised 
population having S. aureus nasal carriage compared to 
37% of the non-hospitalised population.  The incidence of 
S. aureus colonisation appears to be greatest in the 41 to 
65 age group with 54% of the cadavers in that age group 
having S. aureus colonisation.  
 
The picture changes radically when one looks at the 
incidence of Methicillin Resistant S. aureus (MRSA) carriage 
and Methicillin Sensitive S. aureus (MSSA) carriage.  There 
are striking differences between the hospitalised and 
the non-hospitalised group.  Eight out of the 15 S. aureus 
carriers (53%) in the hospitalised group, compared to 4 out 
of the 19 S. aureus carriers (21%) in the non-hospitalised 
group were MRSA positive, with a p value of 0.0505.   
There were gender and age differences. MRSA colonisation 
appears to be relatively more frequent in females, since 
5 out of 9 females had MRSA, when compared to 7 out of 
25 males. None of the cadavers under 40 years of age had 
MRSA.  
Many of the S. aureus nasal carriers exhibited resistance 
to a range of antibiotics (Figure 2).  The resistance was 
much more common in the hospitalised cases, indicating 
that MRSA strains are more aggressive in the hospital 
setting. Most S. aureus strains were resistant to penicillin.  
All the hospitalised cases that were MRSA positive were 
also resistant to ofloxacin, whereas 2 out of the 4 cases 
of MRSA nasal carriage that were not hospitalised before 
death were resistant to ofloxacin. This shows a correlation 
between methicillin/ oxacillin resistance and ofloxacin 
resistance.  
Most of the MRSA cases were also resistant to 
erythromycin with 6 out of the 8 MRSA positive nasal 
carriers that were hospitalised were erythromycin 
resistant.  Two out of the 4 MRSA cases that were not 
hospitalised were also resistant to erythromycin. There 
were 2 cases (1 from the hospitalised group and 1 from 
the non-hospitalised group) which were resistant to 
erythromycin, but were not methicillin resistant.
Some of the cadavers had S. aureus strains which showed 
intermediate resistance to some antibiotics, namely 
fusidic acid (4 cases), fosfomycin (3 cases), rifampicin and 
erythromycin (2 cases each).
Discussion
These results show that hospitalisation increases the 
incidence of MRSA carriage compared to the non-
hospitalised population.  Although the incidence of MRSA 
carriage in the hospitalised group was more than twice 
the incidence in the non-hospitalised group, a p value of 
0.0505 was obtained since a limitation of the study was the 
small number of cases studied.
The incidence of MRSA carriage in the non-hospitalised 
cases in this study is similar to that found by Dall’ Antonia 
et al7 who report an 8% incidence of MRSA in patients on 
admission to a United Kingdom healthcare institution.  
However other studies give a wide range of values; an 
extensive study carried out in the United States showed 
an incidence of MRSA of only 0.8%1 while another study 
in Lahore (Pakistan) showed that MRSA colonisation was 
found in 2.89% of the population.8 Skov9 has shown 
22
that in the Nordic countries (Denmark, Finland, Iceland, 
Norway and Sweden) the incidence of MRSA infections 
was successfully kept at low levels (<1%). This is attainable 
by the conservative use of antimicrobial consumption, 
prescribing of narrow-spectrum antibiotics, screening 
patients, treating MRSA positive patients in isolation and 
the prevention of transmission through appropriate hand 
hygiene.10 When preventive measures are strictly enforced, 
it is possible to keep the incidence of MRSA extremely low.
Between 2008 and 2009, Maltese hospitals reported a 55% 
incidence of MRSA from invasive S. aureus isolates.11 This 
correlates well with the results in this study which have 
shown that more than half of the S. aureus carriers were 
methicillin resistant amongst the hospitalised group.
The widespread use of antibiotics in hospitals is 
universally acknowledged as the critical factor for the 
development of antimicrobial resistance.  It was shown 
that the level of consumption of broad spectrum 
penicillins, especially those containing a beta-lactamase 
inhibitor, cephalosporins, in particular second generation 
cephalosporins, and macrolides at SLH was significantly 
greater than the median obtained from a pan-European 
study entitled ‘Development of Strategies for Control 
and Prevention of Antibiotic Resistance in European 
Hospitals’.12
 
Until recently, most MRSA cases were found in the 
nosocomial setting.  However, community-acquired MRSA 
continues to evolve and has been associated with both 
colonisation and infection. Strains of community-acquired 
MRSA are normally more sensitive to other antibiotics 
than hospital-acquired MRSA strains.13 The incidence of 
MRSA in the community is also on the increase due to the 
widespread and overuse of antibiotics. Since nasal carriage 
triples the chance of developing bacteraemia with S. 
aureus,3 the incidence of MRSA nasal carriage should not 
be underestimated.  
Conclusion
The study shows that hospital stay does not increase  
S. aureus nasal colonisation when compared to the non-
hospitalised group.  However, the incidence of MRSA was 
much higher in the hospitalised group.  The study also 
shows a relatively high incidence of MRSA cases in the 
community.  The prevalence of MRSA nasal carriage both 
in the community (8%) and in the hospital environment 
(19%) should alert our health professionals to the urgent 
need to embark on a strict preventive regime.  
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Figure 1: Flowchart showing summary of findings (n=93)
Figure 2: Incidence of resistance to other antibiotics from S. aureus isolates (n=34)
